Review
Version 1
Preserved in Portico This version is not peer-reviewed
Current Status of Protein Biomarkers in Urolithiasis – a Review of the Recent Literature
Version 1
: Received: 2 October 2023 / Approved: 11 October 2023 / Online: 11 October 2023 (14:12:37 CEST)
A peer-reviewed article of this Preprint also exists.
Lasota, A.; Wasilewska, A.; Rybi-Szumińska, A. Current Status of Protein Biomarkers in Urolithiasis—A Review of the Recent Literature. J. Clin. Med. 2023, 12, 7135. Lasota, A.; Wasilewska, A.; Rybi-Szumińska, A. Current Status of Protein Biomarkers in Urolithiasis—A Review of the Recent Literature. J. Clin. Med. 2023, 12, 7135.
Abstract
Urolithiasis is an increasingly common clinical problem worldwide. The formation of stones is a combination of metabolic status, environmental factors, family history and many other aspects. It’s important to find new ways to quickly detect and assess urolithiasis because it causes sudden, severe pain and often comes back. One way to do this is by exploring new biomarkers. Current advances in proteomic studies provide a great opportunity for breakthroughs in this field. The study focuses on protein biomarkers and their connection to kidney damage and inflammation during urolithiasis.
Keywords
urolthiasis; children; protein biomarkers
Subject
Medicine and Pharmacology, Urology and Nephrology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment